CHIMERIX INC. - COMMON STOCK
3.4900
08-January-25 16:45:00
15 minutes delayed
Stocks
-0.1700
-4.64%
Today's range
3.3950 - 3.6000
ISIN
N/A
Source
NASDAQ
-
Chimerix Appoints Christopher L. Jordan as Vice President, Regulatory Affairs
08 Aug 2022 07:00:00 By Nasdaq GlobeNewswire
-
Chimerix to Present at Wedbush PacGrow Healthcare Conference
02 Aug 2022 07:00:01 By Nasdaq GlobeNewswire
-
01 Aug 2022 16:01:00 By Nasdaq GlobeNewswire
-
24 Jun 2022 10:06:16 By Nasdaq GlobeNewswire
-
Chimerix Announces $9.3 Million International TEMBEXA Procurement Agreement
23 Jun 2022 09:15:16 By Nasdaq GlobeNewswire
-
Chimerix to Present at Jefferies Global Healthcare Conference
01 Jun 2022 16:30:00 By Nasdaq GlobeNewswire
-
Chimerix to Present at H.C. Wainwright Global Investment Conference
17 May 2022 16:15:00 By Nasdaq GlobeNewswire
-
Chimerix Reports First Quarter 2022 Financial Results and Provides Operational Update
16 May 2022 07:00:01 By Nasdaq GlobeNewswire
-
Chimerix Announces Sale of TEMBEXA to Emergent BioSolutions for up to $337.5 Million plus Royalties
16 May 2022 06:30:00 By Nasdaq GlobeNewswire
-
Chimerix to Participate in Maxim Group Panel Discussion
12 May 2022 16:15:00 By Nasdaq GlobeNewswire
-
09 May 2022 07:00:01 By Nasdaq GlobeNewswire
-
Chimerix to Present at Maxim Group 2022 Virtual Growth Conference
21 Mar 2022 07:00:00 By Nasdaq GlobeNewswire
-
Chimerix Reports Fourth Quarter and Year End 2021 Financial Results and Provides Operational Update
01 Mar 2022 07:00:02 By Nasdaq GlobeNewswire
-
22 Feb 2022 07:00:01 By Nasdaq GlobeNewswire
-
Chimerix to Present at B. Riley Virtual Oncology Conference
20 Jan 2022 08:00:02 By Nasdaq GlobeNewswire
-
18 Jan 2022 16:01:00 By Nasdaq GlobeNewswire
-
Chimerix to Present at Virtual H.C. Wainwright BioConnect 2022 Conference
03 Jan 2022 16:45:00 By Nasdaq GlobeNewswire
-
19 Nov 2021 07:00:00 By Nasdaq GlobeNewswire
-
Chimerix to Present at Jefferies London Healthcare Conference
12 Nov 2021 08:00:01 By Nasdaq GlobeNewswire